Dor D. Abelman^1,2, Jenna Eagles^1*, Stephanie Pedersen^1*, Arnavaz Danesh, MSc^1*, Danielle Croucher, PhD, MSc^1*, Jeff P. Bruce, PhD^1*, Stephenie D. Prokopec^1*, Ellen N. Wei, MSc^1*, Saumil Shah, MSc^3*, Alli Murugesan, PhD, MSc^4,5*, Anthony Reiman, MD^3,4,6, Suzanne Trudel, MD, FRCPC^2,7 and Trevor J. Pugh, PhD, FACMG^1,2,8*

¹Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
²Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
³Department of Oncology, Saint John Regional Hospital, Saint John, NB, Canada
⁴Faculty of Medicine, Dalhousie University, Saint John, NB, Canada
⁵Department of Nursing and Health Sciences, Faculty of Science, Applied Science and Engineering, University of New Brunswick, Saint John, NB, Canada
⁶Department of Biological Sciences, University of New Brunswick, Saint John, NB, Canada
⁷Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁸Ontario Institute for Cancer Research, Toronto, ON, Canada

Maria Casanova Espinosa^1*, Miguel Teodoro Hernández Garcia, MD, PhD^2*, Juan Alfonso Soler Campos^3*, Susana Hernández Rodriguez^4*, Maria Jose Moreno Belmonte^5*, Miriam Concepcion Gonzalez Pardo, MD^6,7*, Mercedes Gironella Mesa^8* and Felipe de Arriba de la Fuente^9*

¹Hematology, Hospital Costa del Sol, Marbella, Spain
²Hospital Universitario de Canarias, Tenerife, Spain
³Hematology, Consorci Corporació Sanitària Parc Taulí, SABADELL, ESP
⁴Hematology, Hospital Universitario Basurto, Bizcaia, Spain
⁵Hematology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, ESP
⁶Medical Affairs, Janssen-Cilag, Madrid, Spain
⁷Janssen-Cilag, Madrid, Spain
⁸Hematology, Hospital Universitari Vall d’Hebron, Barcelona, ESP
⁹Hematology, Hospital General Universitario Morales Meseguer, Murcia, Spain

Fan Yang^1* and Juan Li, PhD²

¹The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
²The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou , Guangdong, China

Cecilie Hveding Blimark, PhD, MD^1,2*, Kristina Carlson, MD, PhD^3*, Christopher Day, MD^1*, Sigrun Einarsdottir, MD, PhD^1*, Gunnar Juliusson, MD, PhD⁴, Moshtak Karma, MD^5*, Dorota Knut-Bojanowska, MD^6*, Gunnar Larfors, MD, PhD^7*, Ingemar Turesson, MD, PhD^8*, Mariana Villegas Scivetti, MD^1* and Ingigerdur Sverrisdottir, MD^1,9*

¹Dept. of Haematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden
²Department of Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
³University Hospital Uppsala, Uppsala, Sweden
⁴Lund Stem Cell Center Lund University & Hospital, Lund, Sweden
⁵Haematology department, Södra Älvsborg Hospital, Boras, Sweden
⁶Department of haematology, Uddevalla hospital, Uddevalla, Sweden
⁷Unit of Haematology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden
⁸Skane University Hospital, Malmö, Sweden
⁹Faculty of Medicine, University of Iceland, Reykjavik, Iceland

Ludovic Saba, MD, MSc^*, Chieh-Lin Fu, MD, Kaylee Sarna, MS^*, Hong Liang, PhD^*, Barbara Geraldine Dominguez, MBA^* and Chakra Pani Chaulagain, MD

Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL

Philippe Moreau, MD, PhD^1*, Maria-Victoria Mateos², Hartmut Goldschmidt³, Esther Gonzalez Garcia, MD^4*, Britta Besemer, MD^5*, Marta Sonia Gonzalez Perez^6*, Mohamad Mohty, MD, PhD⁷, Joanne Lindsey-Hill^8*, Suriya Kirkpatrick^9*, Michel Delforge^10*, Emanuele Angelucci¹¹, Francesco Di Raimondo, MD¹², Ravi Vij, MD, MBA¹³, Margaret Doyle¹⁴, Kathleen Gray^15*, Claire Albrecht^16*, Vadim Strulev^17*, Imène Haddad^16*, Silva Saarinen^18*, Lada Mitchell^19*, Jozefien Buyze^17* and Katja Weisel, MD²⁰

¹Hematology Clinic, University Hospital Hotel-Dieu, Nantes, France
²University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
³University Clinic Heidelberg, Heidelberg, Germany
⁴University Hospital Cabueñes, Gijón, Spain
⁵University Hospital of Tuebingen, Tuebingen, Germany
⁶University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
⁷Saint-Antoine Hospital, Sorbonne University, Paris, France
⁸Nottinghamshire University Hospitals NHS Trust, Nottingham, United Kingdom
⁹University of the West of England, Bristol, England, United Kingdom
¹⁰University Hospital Leuven, Leuven, Belgium
¹¹Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova, ITA
¹²Haematology, A.O.U. Policlinico “G. Rodolico-San Marco”, Catania, Italy
¹³Division of Oncology, Washington University School of Medicine, Saint Louis, MO
¹⁴Janssen Global Services, Dublin, Ireland
¹⁵Janssen Research & Development, Bridgewater, NJ
¹⁶Janssen-Cilag, Issy-les-Moulineaux, France
¹⁷Janssen Pharmaceutica NV, Beerse, Belgium
¹⁸Janssen-Cilag, Espoo, Finland
¹⁹Johnson & Johnson, Janssen Pharmaceuticals, Allschwil, Switzerland
²⁰University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Jonathan L. Kaufman, MD¹, Nisha S. Joseph, MD², Vikas A. Gupta, MD, PhD³, Sara Dicamillo^3*, Danielle Roberts^3*, Craig C. Hofmeister, MD³, Madhav V. Dhodapkar, MD, PhD³, Ajay K. Nooka, MD, MPH¹, Sagar Lonial, MD^1* and Lawrence H. Boise³

¹Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
²Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Louisville, KY
³Winship Cancer Institute of Emory University, Atlanta

Steven Graham^1*, Jeff Graham^2*, Julia O'Rourke^2*, Claudia Deveras^3*, Panteli Theocharous, PhD, BSc, FRCPath, MSc^4*, Virgil Rose, MD⁵, Luis Arthur F. Pelloso, MD^4* and Sucha Sudarsanam^6*

¹TrinetX, Cambridge, MA
²TriNetX, Cambridge, MA
³PPD, Unit of Thermo Fisher Scientific, Wilmington, NC
⁴PPD a division of Thermo Fisher Scientific, Wilmington, NC
⁵PPD a division of Thermo Fisher, Wilmington, NC
⁶PPD, unit of Thermo Fisher Scientific, Wilmington, NC

Christoph Driessen, MD¹, Katharina Baur, MD^2*, Dominik Heim, MD², Sabine Gerull, MD³, Christoph Renner, MD^4*, Anne Cairoli, MD^5*, Thomas Pabst, MD⁶, Joerg Halter, MD^2*, Michael Gregor^7*, Nicole Graf^8*, Nino Fejzibegovic^4*, Nathan Wolfensberger, MD^9*, Federico Simonetta, MD, PhD^10*, Martin Fehr, MD^1*, Esteban Ciliberti^11*, Rouven Müller, MD^12* and Barbara Jeker^6*

¹Division of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
²Division of Hematology, University Hospital Basel, Basel, Switzerland
³Kantonsspital Aarau, Aarau, Switzerland
⁴Department of Hematology and Medical Oncology, Hirslanden Clinic Zurich, Zurich, Switzerland
⁵Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
⁶Department of Medical Oncology, Bern University Hospital, Bern, Switzerland
⁷Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland, Luzern, Switzerland
⁸Clinical Trials Unit, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
⁹Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland
¹⁰Division of Oncology and Hematology, University Hospital Geneve, Geneve, Switzerland
¹¹Ente Ospedaliero Cantonale Lugano, Lugano, Switzerland
¹²Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland

Rakesh Popat^1*, Kathleen Cheok, MBBS², Amrutha Sridhar^2*, Conor Feely^2*, Catriona Mactier^3*, Annabel Mcmillan^4*, Ashutosh D. Wechalekar, MBBS, DM, FRCP, FRCPath⁵, Neil Rabin^3*, Jonathan Sive, MD^3*, Charalampia Kyriakou, MD, PhD^3*, Ke Xu^3*, Xenofon Papanikolaou^3*, Shameem Mahmood^3*, Kwee Yong⁶ and Lydia Sarah Hui Lee, MD PhD^7*

¹University College London, London, United Kingdom
²NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom
³University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁴Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁵Royal Free London Hospital, National Amyloid Centre, London, GBR
⁶Department of Haematology, University College London, London, United Kingdom
⁷Department of Hematology, UCL Cancer Institute, London, United Kingdom

Elizabeth XISTO Souto, MD^1*, Laiz CAMEIRAO Bento, MSC^2*, Flavia ARANDAS Sousa, MSC^3*, Marilia SANDOVAL Passaro^4*, Andressa DA COSTA Vaz^4*, Daniela Schimidell^4*, Barbara FAZIALI Bueno^4*, Priscila CARMONA Myiamoto, MSC^4*, Bruna GARCIA Nogueira^4*, Joao Carlos Guerra, MD, PhD^5*, Andrea Rocco Villarinho^6* and Nydia Bacal, MD, MBA^7*

¹Laboratory Flow Cytometry, Albert Einstein Hospital, Sao Paulo, São Paulo, Brazil
²Laboratory flow cytometry, Albert Einstein Hospital, Sao Paulo, Brazil
³Laboratory flow cytometry, Albert Einstein Hospital, sao Paulo, Brazil
⁴Laboratory flow cytometry, Albert Einstein Hospital, SAO PAULO, Brazil
⁵Laboratory, Albert Einstein Hospital, Sao Paulo, Brazil
⁶Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil
⁷Laboratory flow cytometry, Albert Einstein HOspital, sao paulo, Brazil

Sigrun Einarsdottir, MD, PhD^1,2*, Ingigerdur Sverrisdottir, MD^1,3*, Mariana Villegas Scivetti, MD^1*, Christopher Day, MD^1*, Ingemar Turesson, MD, PhD^4*, Gunnar Juliusson, MD, PhD⁵, Kristina Elisabet Carlson, MD, PhD⁶, Gunnar Larfors, MD, PhD^6,7* and Cecilie Hveding Blimark, PhD, MD^1,2*

¹Dept. of Haematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden
²Department of Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
³Faculty of Medicine, University of Iceland, Reykjavik, Iceland
⁴Skane University Hospital, Malmö, Sweden
⁵Lund Stem Cell Center Lund University & Hospital, Lund, Sweden
⁶Department of Medical Sciences, Uppsala University, Uppsala, Sweden
⁷Unit of Haematology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Megan Braunlin, MPH^1*, Rani Najdi^2*, Mukta Arora^2*, Amy Kimball², Rong Tilney^3* and Ian McFadden^2*

¹Amgen Inc., Austin, TX
²Amgen Inc., Thousand Oaks, CA
³Simulstat Inc., Sonala Beach, CA

Gianluca Cavallaro^1*, Monica Galli^2*, Laura Paris^3*, Paola Stefanoni^4*, Chiara Pavoni^5*, Silvia Mangiacavalli, MD^6*, Valeria Masoni^7*, Michele Palumbo^7*, Alessandra Pompa^8*, Anna Maria Cafro, MD^9*, Sara Pezzatti^10*, Stefano Crippa^10* and Alessandro Rambaldi⁴

¹Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Verdello, Italy
²Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
³ASST Papa Giovanni XXIII, Bergamo, Italy
⁴Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
⁵Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁶Department of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
⁷Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁸Division of Hematology and Stem Cell Transplantation, Fondazione Ca'Granda IRCCS Ospedale Maggiore Policlinico, Milan, Italy, Milano, ITA
⁹Department of Hematology, GOM Niguarda Hospital, Milan, Milan, ITA
¹⁰Department of Hematology and Transplantation, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, St Gerardo Hospital, Monza, Italy

Dickran Kazandjian, MD¹, Hang Quach, MD, FRACP, FRCPA, MBBS², Hanlon Sia^3*, Phoebe Joy Ho, MBBS, FRACP, FRCPA⁴, Andrew Spencer, MBBS, MD, FRACP, FRCPA^5*, Mark A. Schroeder, MD⁶, Binod Dhakal, MBBS⁷, Tara Cochrane, MBBS, FRCPA, FRACP⁸, Jeffrey A. Zonder, MD⁹, Nancy Yi^10*, Dominique Duchesne^11*, Tejas Shah^11*, Andrew Garton, PhD^11*, Vinu Menon^12*, Sunitha Gn^13*, Stefano Sammicheli^14*, Eugene Zhukovsky^14*, Cyril Konto, MD¹², Lida Pacaud, MD^12* and Peter Tan^15*

¹Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
²St Vincent's Hospital - University of Melbourne, Melbourne, Australia
³Pindara Private Hospital, Benowa, QLD, AUS
⁴Institute of Haematology Royal Prince Alfred Hospital, University of Sydney, Sydney, AUS
⁵The Alfred Hospital, Melbourne, VIC, AUS
⁶Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University, Saint Louis, MO
⁷BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁸Department of Haematology, Gold Coast University Hospital, Southport, Australia
⁹Karmanos Cancer Institute, Detroit, MI
¹⁰Ichnos Sciences Inc., New York, NY
¹¹Ichnos Sciences Inc., New York
¹²Ichnos Sciences, New York, NY
¹³Glenmark Pharmaceuticals Limited, Mumbai, India, Mumbai, India
¹⁴Ichnos Sciences Biotherapeutics SA, Lausanne, Switzerland
¹⁵One Clinical Research, Nedlands, Australia

Yogesh Chawla, PhD^1*, Emilie Anderson, M.S.^1*, Isas Rosario Vasquez^1*, Rachel A Simon^1*, Taro Hitosugi², Shaji Kunnathu Kumar, MD¹ and Wilson I. Gonsalves, MD^1,3

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Oncology, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN

Andrew Kowalski, PharmD^1*, Jillian Lorayne Lykon, PharmD^2*, Benjamin Diamond, M.D.^3*, David Coffey, MD⁴, Marcella Kaddoura, MD⁵, Francesco Maura, MD⁶, James E. Hoffman, MD⁷, Dickran Kazandjian, MD⁸ and Ola Landgren, MD³

¹Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL
²Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
³Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
⁴Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁵Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Dearborn, MI
⁶Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, PALMETTO BAY, FL
⁷University of Miami Health System, Fort Lauderdale, FL
⁸Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami

Catherine SY Lecat, MBBS^1*, Alan Chant^2*, Orla McCourt, PhD^3,4*, David Meads, PhD^5*, Robert Cicero, MSc^6*, Kara-Louise Royle^6*, Ceri Bygrave, MD, FRCPath, MPhil^7*, Andrew Chantry^8*, Michael A. Chapman, MD PhD^9,10, Gordon Cook, PhD^6,11*, Bryony Dawkins^5*, Mark Drayson^12*, Graham Jackson^13*, Matthew W. Jenner^14*, Martin F. Kaiser, MD, FRCP, FRCPath^15,16, Dipal Mehta, MBBS MRCP^17*, Roger Owen, MD, MRCP, FRCPath^18*, Rakesh Popat^3,19*, Christopher Parrish^20*, Guy Pratt^21*, Jonathan Sive, MD^3,22*, Dean Smith^23*, Ruth M de Tute, MSc, PhD, FRCPath^24*, Lorna Barnard^6*, Sharon Jackson^25*, Doina Levinte^6*, Catherine Olivier^6*, Karthik Ramasamy, MD²⁶, Kwee Yong^4,27 and David Allan Cairns, PhD^28*

¹Department of Hematology, UCL Cancer Institute, London, United Kingdom
²Patient and Public Contributor, NA, United Kingdom
³Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁴Research Department of Haematology, University College London Cancer Institute, London, United Kingdom
⁵University of Leeds, Academic Unit of Health Economics, Leeds, United Kingdom
⁶Leeds Institute of Clinical Trials Research, Cancer Research UK Clinical Trials Unit, Leeds, United Kingdom
⁷Haematology, University Hospital Wales, Cardiff, United Kingdom
⁸University of Sheffield, Department of Oncology and Metabolism The Medical School Beech Hill Road, Sheffield, GBR
⁹Department of Haematology, University of Cambridge, Cambridge, United Kingdom
¹⁰MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom
¹¹Leeds Myeloma Research Group and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom
¹²University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom
¹³University of Newcastle, Department of Haematology, Newcastle, United Kingdom
¹⁴University Hospital Southampton, Southampton, United Kingdom
¹⁵The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
¹⁶The Institute of Cancer Research, London, ENG, United Kingdom
¹⁷UCL, London, United Kingdom
¹⁸Leeds Teaching Hospitals NHS Trust, Haematological Malignancies Diagnostics Service, Leeds, United Kingdom
¹⁹University College London, London, United Kingdom
²⁰St James's Institute of Oncology, Leeds, GBR
²¹University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
²²University College London Hospitals NHS Foundation Trust, London, United Kingdom
²³Department of Clinical Haematology, Nottingham University Hospitals, Nottinghamshire, United Kingdom
²⁴HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
²⁵Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
²⁶Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
²⁷Department of Haematology, University College London, London, United Kingdom
²⁸Leeds Institute of Clinical Trials Research, Cancer Research UK Clinical Trials Unit, Leeds, ENG, United Kingdom

Pascal Chanu, PharmD^1*, Sandhya Balasubramanian, MS^2*, Divya Samineni, PhD^2*, Monica Susilo, PhD^2*, Maika Onishi, MD², Felipe A Castro, PhD^3*, Madlaina Breuleux, PhD^3*, Jin Jin, PhD^2*, Chunze Li, PhD^2* and René Bruno, PhD^4*

¹Genentech/Roche, Lyon, France
²Genentech Inc., South San Francisco, CA
³Roche, Basel, Switzerland
⁴Genentech/Roche, Marseille, France

Oren Pasvolsky, MD^1*, Michelle Hildebrandt, PhD², Naveen Subramanian, MD³, Christopher Ferreri, MD^4*, Hans Lee, MD⁵, Elisabet E. Manasanch, MD^6*, Sheeba K. Thomas, MD⁶, Donna M. Weber, MD⁶, Mahmoud Gaballa, MD⁶, Christen Dillard, MD^2*, Melody Becnel, MD⁷, Chitra Hosing, MD¹, Pei Lin, MD, DM, MDPC⁸, Behrang Amini, MD, PhD^9*, Muzaffar H. Qazilbash, MD¹, Nilesh Kalariya, PhD, RN^6*, Robert Z. Orlowski, MD, PhD¹⁰ and Krina K. Patel, MD, MSc¹¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Internal Medicine, The University of Texas Health Sciences Center at Houston, Austin, TX
⁴MD Anderson Cancer Center, Houston
⁵Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston
⁸Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, TX
¹¹University of Texas MD Anderson Cancer Center, Houston, TX

Massimo Offidani, MD^1*, Carmela Zizzo^2*, Sonia More'^1*, Irene Federici^1*, Alessandra Bossi^1*, Valentina Maria Manieri^1*, Maria Teresa Petrucci^3*, Francesca Fazio^3*, Chiara Lisi^3*, Francesca Farina^4*, Marino Brunori^5*, Francesca Fioritoni^6*, Nicola Sgherza^7*, Rosa De Francesco^8*, Tommaso Caravita di Toritto^9*, Attilio Tordi^9*, Angela Amendola^10*, Assunta Melaccio^11*, Silvia Gentili^12*, Lucia Ciuffreda^13*, Maria Livia Del Giudice^14*, Antonietta Pia Falcone, MD, PhD^15*, Alessandro Gozzetti^16*, Simona Tomassetti^17*, Anna Mele^18*, Miriana Ruggieri^19*, Agostina Siniscalchi^20*, Rosario Bianco^21*, Antonino Greco^18*, Antonio Giovanni Solimando^22*, Francesco Rotondo^23*, Fabio Trastulli^24*, Laura Corvatta^25*, Erika Morsia^1*, Serena Rupoli^1*, Shahram Kordasti, MD, PhD²⁶, Attilio Olivieri^1* and Giovanni Duro^2*

¹Clinica di Ematologia Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy
²Istituto per la Ricerca e l’Innovazione Biomedica CNR-Palermo, Palermo, Italy
³Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Roma, Italy
⁴IRCCS Ospedale San Raffaele, Milano, Italy
⁵Ematologia Ospedale Santa Croce Fano, Fano, Italy
⁶Department of Haematology, Pescara, ITA
⁷Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy
⁸Ospedale Cardinale G. Panico Tricase, Tricase, Italy
⁹Ematologia, Ospedale Santo Spirito ASL Roma1, Roma, ITA
¹⁰Ematologia, AOR San Carlo, Potenza, Potenza, ITA
¹¹Ematologia, U.O. G. Baccelli Policlinico di Bari, Bari, Italy
¹²Medicina Interna, Ospedale Civitanova Marche, Civitanova Marche, Italy
¹³Ematologia, Azienda Ospedaliero Universitaria Ospedali Riuniti di Foggia, Foggia, Italy
¹⁴Ematologia, Azienda Ospedaliera Pisana, Pisa, Italy
¹⁵IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, ITA
¹⁶Azienda ospedaliero-universitaria Senese, Siena, Italy
¹⁷Ematologia, Ospedale Infermi di Rimini, Rimini, Italy
¹⁸Ematologia, Ospedale Cardinale G. Panico Tricase, Tricase, ITA
¹⁹Ematologia, Ospedale C. e G. Mazzoni, Ascoli Piceno, Italy
²⁰UOSD Ematologia, ASL Roma 1, Roma, ITA
²¹UOC Ematologia, AORN Sant’Anna e San Sebastiano di Caserta, Caserta, ITA
²²Medicina interna universitaria Guido Baccelli, Ospedale Policlinico di Bari, Bari, Italy
²³Ematologia, Ospedale Infermi di Rimini, Rimini, ITA
²⁴Ematologia, AORN A. Cardarelli, Napoli, Napoli, ITA
²⁵UOC Medicina, Ospedale Profili, Fabriano, ITA
²⁶King's College London, London, United Kingdom

Adam Sciambi, PhD^1*, Cedric Dos Santos, PhD², Yang Li^3*, Joanne Bio Nguyen^3*, Priyam Priyam^3*, Vivek Chopra, PhD^2*, Habib Hamidi, MPH, PhD^2*, Michael Nixon^4*, Yann Nouet, PhD MSc⁵, Todd E. Druley, MD, PhD^3* and Herve Avet-Loiseau, MD, PhD^6*

¹Mission Bio Inc, South San Francisco
²Genentech, Inc., South San Francisco, CA
³Mission Bio, Inc, South San Francisco, CA
⁴Roche, Indianapolis, IN
⁵F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁶Institut universitaire du cancer de Toulouse Oncopole, Toulouse, France

Tadeusz Kubicki^1,2*, Dominik Dytfeld^2*, Tomasz Wrobel, MD, PhD^3*, Krzysztof Jamroziak^4*, Pawel Robak^5*, Jaroslaw Czyz^6*, Agata Tyczynska^7*, Agnieszka Druzd-Sitek^8*, Krzysztof Giannopoulos^9*, Adam Nowicki^2*, Tomasz Szczepaniak^2*, Anna Lojko-Dankowska^2*, Magdalena Matuszak^2*, Lidia Gil², Bartosz Michal Pula^4*, Justyna Rybka^3*, Maciej Majcherek^3*, Lidia Usnarska-Zubkiewicz^3*, Lukasz Szukalski^6*, Agnieszka Konska^4*, Jan M. Zaucha^7*, Jan Walewski⁸, Damian Mikulski^5*, Olga Czabak^10*, Tadeusz Robak^5*, Dorota Kruk-Kwapisz^11*, Oscar Boutros Lahoud¹², Jeffrey A. Zonder, MD¹³, Kent Griffith^14*, Andrew T Stefka^1*, Ken Jiang^1*, Jennifer H Cooperrider¹, Ben A Derman, MD¹⁵ and Andrzej J Jakubowiak, MD, PhD¹

¹University of Chicago, Chicago, IL
²Poznan University of Medical Sciences, Poznan, Poland
³Wroclaw Medical University, Wroclaw, Poland
⁴Institute of Hematology and Blood Transfusion, Warsaw, Poland
⁵Medical University of Lodz, Lodz, Poland
⁶Nicolaus Copernicus University in Torun Ludwik Rydygier, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland
⁷Medical University of Gdansk, Gdansk, Poland
⁸Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland
⁹Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland
¹⁰Medical University of Lublin, Lublin, Poland
¹¹Clinscience, Warsaw, Poland
¹²Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Karmanos Cancer Institute, Detroit, MI
¹⁴University of Michigan Health System, Ann Arbor, MI
¹⁵University of Chicago, CHICAGO, IL

Lauren Campbell, PhD^1*, Karthik Ramasamy² and Ross Sadler^1*

¹Immunology Laboratory, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
²Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Sarvarinder Kaur Gill^1*, Noa Biran, MD², Pooja Phull, MD^2*, David H. Vesole, MD, PhD², David S. Siegel, MD, PhD^3,4 and Harsh Parmar, MBBS⁵

¹John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
²Multiple Myeloma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
³Multiple Myeloma Division, Hackensack Univ. Med. Ctr., Hackensack, NJ
⁴Center for Discovery & Innovation, Hackensack Meridian Health, Nutley, NJ
⁵Multiple Myeloma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ

Sterling Rosqvist, MD^1*, Victoria A. Vardell, MD^1,2, Eric Anto, M.S.^3*, Gliceida Galarza Fortuna, MD^1*, Douglas Peters, MD^1*, Charlotte B Wagner, PharmD^4*, Baylee Bryan, PharmD^4*, Mary Nicole Steinbach, APRN^1*, Samuel Shewan, PA-C^1*, Lindsay Maxwell, APRN^1*, Michael R. Savona, MD⁵, Kelley Julian, PharmD, BCOP^4*, Brian McClune, DO², Ghulam Rehman Mohyuddin, MD², Amandeep Godara, MD², Muhamed Baljevic, MD^5* and Douglas Sborov, MD, MS⁶

¹Department of Internal Medicine, University of Utah, Salt Lake City, UT
²Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
³Department of Population Sciences, University of Utah, Salt Lake City, UT
⁴College of Pharmacy, University of Utah, Salt Lake City, UT
⁵Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
⁶Huntsman Cancer Institute, University of Utah, Salt Lake Cty, UT

Beatrice Fregonese, MPH^*, Brandon S. Imber, MD, MA, Alexandra Dreyfuss, MD, MSTR^*, Carla Hajj, MD^* and Joachim Yahalom, MD

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

Niraj Neupane, MD^1*, Arnav Srivastava^1*, Shubham Agrawal, MD^2*, Anish Shah^3*, Pravash Budhathoki^4*, Amir Mahmoud, MD, MSc¹, Aditya Sanjeevi, MD^1*, Himal Kharel, MD^1*, Utsav Joshi, MBBS⁵ and Binod Dhakal, MBBS⁶

¹Rochester General Hospital, Rochester, NY
²Mercy catholic medical center, Philadelphia
³Bronxcare Health System, Mahottari, Nepal
⁴Bronxcare Health System, Bronx, NY
⁵Moffitt Cancer Center, Tampa
⁶BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Abinesh Sekar¹, Chidambaram Ramasamy, MD^2*, Harinivaas Shanmugavel Geetha, MD^3*, Madhan Srinivasan Kumar, MD³, Masood Pasha Syed, MD^4*, Kala Seetharaman, MD^5* and George M. Abraham, MD, MPH, MACP, FIDSA, FRCP (Lon.)^3*

¹Saint Vincent Hospital, Worcester, MA
²Hematology and Oncology, University of Connecticut, Hartford, CT
³Internal Medicine, Saint Vincent Hospital, Worcester, MA
⁴Hematology & Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA
⁵Division of Blood Disorders and Cancer Medicine, Saint Vincent Hospital, Worcester, MA

Andrew McPherson, PhD^1*, Kylee H Maclachlan, MBChB, PhD², Matthew Myers, PhD^3*, Gryte Satas, PhD^3*, Ola Landgren, MD⁴, Saad Z Usmani, MD², Sohrab P Shah^5* and Francesco Maura, MD⁶

¹Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
²Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Computational Oncology Service, Memorial Sloan Kettering Cancer Center, New York
⁴Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, PALMETTO BAY, FL

Gunnar Larfors, MD, PhD^1*, Kristina Elisabet Carlson, MD, PhD^1,2, Christopher Day, MD^3*, Sigrun Einarsdottir, MD, PhD^4*, Gunnar Juliusson, MD, PhD⁵, Moshtak Karma, MD^6*, Dorota Knut-Bojanowska, MD^7*, Ingigerdur Sverrisdottir, MD^3,8*, Ingemar Turesson, MD, PhD^9*, Mariana Villegas Scivetti, MD^3* and Cecilie Hveding Blimark, PhD, MD^3,4*

¹Department of Medical Sciences, Uppsala University, Uppsala, Sweden
²Uppsala University, Uppsala, SWE
³Dept. of Haematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden
⁴Department of Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
⁵Lund Stem Cell Center Lund University & Hospital, Lund, Sweden
⁶Haematology department, Södra Älvsborg Hospital, Boras, Sweden
⁷Department of haematology, Uddevalla hospital, Uddevalla, Sweden
⁸Faculty of Medicine, University of Iceland, Reykjavik, Iceland
⁹Skane University Hospital, Malmö, Sweden

Arooj Ahmed, MD^1*, Danai Dima, MD², Kerri Row, PharmD^2*, Fauzia Ullah, MD^2*, Hussein Awada^2*, Diana Basali, MD², Heena Kurish, PharmD^2*, Mikhaila Rice, PharmD^3*, Joslyn Rudoni, PharmD^3*, Marissa Duco, PharmD^2*, Beth M. Faiman, PhD, CNP², Jack Khouri, MD², Sandra Mazzoni, DO^2*, Louis S. Williams, MD², Shahzad Raza, MD^2*, Christy J. Samaras, DO², Jason Valent, MD² and Faiz Anwer, MD²

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³Department of Pharmacy, Cleveland Clinic, Cleveland, OH

Zhao Zeng^1*, Chengcheng Fu^2*, Jinlan Pan^3*, Jiao Lu^4,5*, Jingjing Shang^6*, Zhiyu Zhang^1*, Hongying You^1*, Wanhui Yan^1*, Chunxiao Wu^6*, Qinrong Wang^7*, Qian Wang^3*, Lijun Wen, MD^8*, Song Jin^9*, Lingzhi Yan^9*, Suning Chen^10* and De-pei Wu³

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
²Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China
³National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China, Suzhou, China
⁴National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China., Suzhou, Jiangsu, China
⁵Department of Haematology, Jingjiang People’s Hospital, the Seventh Affiliated Hospital of Yangzhou University, Jingjiang, Jiangsu, China
⁶The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, Jiangsu, China
⁷The First Affiliated Hospital of Suzhou, Suzhou, Jiangsu, China
⁸National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
⁹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Soochow University,, Suzhou, China
¹⁰National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China

Shuchan Li^1*, Xiaoyan Han^2*, Gaofeng Zheng, MD^2*, Jingsong He^3*, Wenjun Wu, MD^2*, Yang Yang^4*, Qingxiao Chen, MD^1*, Donghua He^2*, Mengmeng Dong^5*, Jinuo Wang, MD^6*, Yi Li^1*, Li Yang^7* and Zhen Cai^5*

¹Department of Hematology and Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
²Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Hangzhou, China
³The Department of Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁴Department of Hematology and Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Hangzhou, China
⁵Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁶the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁷The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, CHN

Aytaj Mammadzadeh^1,2*, Yara Shatnawi, MD^2,3*, Rawan Atallah^2,4*, Benlazar Mohamed, MD^5*, Nihar Desai, MBBS^6*, Shahrukh K Hashmi, MD, MPH^7,8*, Thiago Xavier Carneiro, MD^9*, Hira Shaikh, MBBS^2,10*, Christopher Strouse, MD^2,11, Rakesh Popat^12*, Zahra Mahmoudjafari, PharmD^2,13*, Muhammad Umair Mushtaq, MD^2,13, Al-Ola Abdallah, MD^2,13 and Nausheen Ahmed, MD^2,13*

¹Division of Hematology/Oncology, Mayo Clinic, Rochester, MN
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Jordan University of Science & Technology, Irbid, Jordan
⁴Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Redwood City, CA
⁵Hematology Department, University of Sidi Bel Abbès, Sidi Bel Abbès, Algeria
⁶Princess Margaret Cancer Centre, Toronto, ON, Canada
⁷Department of Medicine, Mayo Clinic, Rochester, MN
⁸Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates
⁹Hospital Ophir Loyola/State University of Para, Belém, PA, Brazil
¹⁰Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa City, IA
¹¹Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa city, IA
¹²Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS

Yael C. Cohen^1,2*, Gil Fridberg^3,4*, Inbar Cohen, MD^1,5*, Renana Robinson, MD^1,6*, Iuliana Vaxman, MD^7*, Tamir Shragai, MD^7,8*, Svetlana Trestman, MD^7,9*, Tomer Ziv-Baran, PhD^10*, Natan Melamed^2*, Pia Raanani, MD^1,11 and Irit Avivi Mazza, MD^1,12*

¹Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
³Hematology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
⁴Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Tel Aviv, Israel
⁵Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Tel Aviv, Israel
⁶Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
⁷Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, tel aviv, Israel
⁸Hematology Division, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel
⁹Hematology Division, Tel Aviv Sourasky Medical Center, tel aviv, Israel
¹⁰School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Tel Aviv, Israel
¹¹Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
¹²Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Kari Lenita Falck Moore^1,2,3*, Anna Genell^4*, Ain Kaare, MD^5*, Dorota Knut-Bojanowska, MD^6*, Diana Loigom^7*, Anna Lysen, PhD^8,9*, Jakob Nordberg Nørgaard^10,11*, Katrin Palk^7*, Maris Pärnat^5*, Valdas Peceliunas, MD, PhD^12,13*, Sæmundur Rögnvaldsson, MD, PhD^14,15*, Fredrik Schjesvold, MD, PhD^9,16, Alexander Sigurdsson^17*, Agoston Gyula Szabo, MD^18,19, Jonathan Thorsen^20*, Sigrun Thorsteinsdottir, MD, PhD^15,21, Vilmantė Vaitekėnaitė, MD^13,22*, Annette Vangsted^18* and Cecilie Hveding Blimark, PhD, MD^23,24*

¹Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
²K.G. Jebsen Center for B cell malignancies, Institute of clinical medicine, University of Oslo, Stavanger, Norway
³Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway
⁴Regional Cancer Center of the Western Region, Sahlgrenska University Hospital, Gothenburg, Sweden
⁵Department of Hematology and Bone Marrow Transplant, Tartu University Hospital, Tartu, Estonia
⁶Department of haematology, Uddevalla hospital, Uddevalla, Sweden
⁷Centre of Haematology, North Estonia Medical Centre Foundation, Tallinn, Estonia
⁸KG Jebsen Center for B Cell Malignancies, Institute of clinical medicine, University of Oslo, Oslo, Norway
⁹Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway
¹⁰KG Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
¹¹Oslo Myeloma Center, Department of hematology, Oslo University Hospital, Oslo, Norway
¹²Department of Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
¹³Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
¹⁴Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland
¹⁵Faculty of Medicine, University of Iceland, Reykjavik, Iceland
¹⁶KG Jebsen Center for B cell malignancies, Institute of clinical medicine, University of Oslo, Oslo, Norway
¹⁷Reykjavík Primary Health Care Center, Reykjavik, Iceland
¹⁸Department of Hematology, Rigshospitalet, Copenhagen, Denmark
¹⁹Department of Hematology, Vejle Hospital, Humlebæk, Denmark, Denmark
²⁰Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark
²¹Department of Hematology, Rigshospitalet, København, Copenhagen, Denmark
²²Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
²³Dept. of Haematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden
²⁴Department of Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

F. Lennie Wong, PhD¹, Scott R. Goldsmith², Kimlin Ashing, PhD^1*, Amrita Krishnan, MD³, Michael Rosenzweig⁴ and Saro Armenian, DO, MPH⁵

¹City of Hope, Duarte, CA
²City of Hope Comprehensive Cancer Center, Duarte, CA
³Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Irvine, CA
⁴Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
⁵City of Hope National Medical Center, Duarte, CA

Andy Tang, MD, BMedSci, MRCP(UK), FRCPath(UK)^1*, Kihyun Kim, MD, PhD², Fiona Chen, BBiomedSc (Hons), PhD^3*, Zoe K McQuilten, MBBS, PhD, FRACP, FRCPA^4,5*, Peter Mollee, FRACP, MBBS, MSc, FRCPA⁶, Rajeev Rajagopal^7*, Hang Quach, MD, FRACP, FRCPA, MBBS⁸, Phoebe Joy Ho, MBBS, FRACP, FRCPA⁹, Simon J. Harrison, MBBS, MRCP, FRCPath, FRACP, PhD¹⁰, Andrew Spencer, MBBS, MD, FRACP, FRCPA^11,12* and Wee-Joo Chng, MBBS, PhD, FRCPath, FRCP^13,14,15

¹National University Cancer Institute, Singapore, Singapore
²Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Seoul, Korea, Republic of (South)
³School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
⁴Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
⁵Department of Haematology, Monash Health, Melbourne, Australia
⁶Princess Alexandra Hospital, Brisbane, Australia
⁷Middlemore Hospital, Auckland, New Zealand
⁸St. Vincent's Hospital Melbourne, East Melbourne, Australia
⁹Royal Prince Alfred Hospital, Sydney, AUS
¹⁰Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, AUS
¹¹Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia
¹²Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
¹³National University Hospital National University Cancer Institute, Singapore, Singapore
¹⁴Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
¹⁵Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

Jing Wang^1*, Na Shen^1*, Xuxing Shen^1*, Run Zhang^1*, Yuan Jin^1*, Jianyong Li, MD² and Lijuan Chen^3*

¹Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
²Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
³Department of Hematology, Jiangsu Province Hospital and The First Affiliated Hospital with Nanjing Medical University, Nanjing, China

Jiri Minarik, MD¹, Ludek Pour, MD^2*, Tomas Jelinek, MD, PhD³, Ivan Spicka^4*, Alexandra Jungova, MD, Ph.D.^5*, Jakub Radocha, MD, PhD⁶, Petr Pavlicek^7*, Tomas Pika^8*, Martin Stork^9*, Jan Straub^10*, Vladimir Maisnar^11* and Roman Hajek, MD¹²

¹Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olumouc, Czech Republic
²Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
³Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, Ostrava, Czech Republic
⁴Charles University Hospital Kralovske Vinohrady, Prague, Czech Republic
⁵Charles University Hospital Pilsen, Hematology and Oncology Department, Pilsen, CZE
⁶4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
⁷3rd Faculty of Medicine, Charles University and Faculty Hospital Kralovske Vinohrady, Department of Internal Medicine and Hematology, Prague, Czech Republic
⁸Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
⁹Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
¹⁰1st Medical Department – Clinical Department of Haematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Praha 2, Czech Republic
¹¹4th Department of Medicine - Haematology, Charles University Hospital, Hradec Králové, CZE
¹²University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

Efstathios Kastritis, MD^1*, Meral Beksac, MD², Sorina Nicoleta Badelita, MD^3*, Eirini Katodritou, MD^4*, Jelena Bila^5*, Emmanouil Spanoudakis^6*, Guldane Cengiz Seval, MD^7*, Zorica Cvetkovic, MD, PhD^8*, Olivera Markovic, MD, PhD^9*, Selami Kocak Toprak^10*, Dimitra Dalampira, MD^11*, Daniel Coriu, PhD^12*, Zoi Bezirgiannidou^13*, Mario Pirsic^14*, Toni Valkovic^15*, Iulia Ursuleac^12*, Aleksandra Sretenovic^5*, Angeliki Sevastoudi, MD^16*, Josip Batinic^17,18*, Sinziana Barbu^3*, Maria Roussou, MD^1*, Maria Gavriatopoulou, MD, PhD^1*, Evangelos Terpos, MD, PhD¹ and Meletios A. Dimopoulos, MD, PhD¹

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Department of Hematology, Ankara University, Ankara, Turkey
³Department of Hematology, Fundeni Clinical Institute, Bucharest, Romania
⁴Theagenion Cancer Hospital, Thessaloniki, Greece
⁵Clinic of Hematology, University Clinical Center of Serbia, University of Belgrade, Medical Faculty, Belgrade, Serbia
⁶Department of Hematology, University Hospital of Alexandroupolis, Alexandroupolis, Greece
⁷Department of Hematology, Ankara University Faculty Of Medicine Cebeci Hospital, Ankara, Turkey
⁸Department of Hematology Clinical Hospital Center Zemun, University of Belgrade, Belgrade, Serbia
⁹Clinical Hospital Center "Bezanijska Kosa", Belgrade, Serbia
¹⁰Department of Hematology, Ankara University Faculty of Medicine, Ankara, Turkey
¹¹Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, AL, Greece
¹²Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
¹³Department of Hematology, Democritus University of Thrace, Alexandroupolis, Greece
¹⁴Division of Hematology, Department of Internal Medicine, University Hospital Dubrava, Zagreb, Croatia
¹⁵University Hospital Centre Rijeka, Rijeka, Croatia
¹⁶Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
¹⁷Division of Hematology, Department for Internal Medicine, University Hospital Centre Zagreb, Zagreb, Croatia
¹⁸School of Medicine, University of Zagreb, Zagreb, Croatia

Jean-Richard Eveillard, MD^1*, Nathalie Douet-Guilbert^2*, Audrey Basinko^2*, Romuald Kerdoncuff^3*, Adrian Tempescul, MD^1*, Hussam Saad, MD^1*, Charazed Bekara^1*, Zoé Bezagu^1*, Moriamo Eniafe-Eveillard, MD^4*, Christophe Nicol, MD^5* and Jean-Christophe Ianotto, MD, PhD^1*

¹Hematology, CHRU de Brest, Brest, France
²Laboratory of Genetics, CHRU de Brest, Brest, France
³Center for Clinical Investigation, CHRU de Brest, Brest, France
⁴Occupational Medicine, CHRU de Brest, Brest, France
⁵CH de Morlaix, Morlaix, France

Benjamin Hebraud, MD^1*, Miguel Granell, MD^2*, Leopoldine Lapierre, MD^2*, Pierre Luc Mouchel, MD PhD^3*, Guillaume Beziat^2*, Nina Sicard^4*, Maeva Bonneau^2*, Jules Higue^5*, Florence Sougy^4*, Sophie Perriat, PharmD^6*, Charlotte Morel, PharmD^7*, Pierre Bories, MD, PhD^8*, Jill Corre, PharmD, PhD^9*, Herve Avet Loiseau, MD, PhD¹⁰, Christian Recher, MD, PhD^11* and Aurore Perrot, MD, PhD¹²

¹Service Hematologie, Institut Universitaire du Cancer de Toulouse / CHU de Toulouse, Toulouse, France
²Service Hematologie, CHU de Toulouse, IUCT-O, Toulouse, France
³Service Hematologie, CHU de Toulouse, IUCT-O, Toulouse, FRA
⁴CHU de Toulouse, IUCT-O, Toulouse, France
⁵Service d'Hematologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
⁶Pharmacy Department, IUCT Oncopole, Toulouse, France
⁷Onco-Occitanie Network, Toulouse, France
⁸Early Phase Unit, University Cancer Institute Toulouse Oncopole, Toulouse, France
⁹Institut universitaire du cancer de Toulouse Oncopole,, Toulouse, France
¹⁰Unité Génomique du Myélome, University Hospital Toulouse, IUCT Oncopole, Toulouse, France
¹¹Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
¹²CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France

Julius Enssle, MD^1*, Tonio Brinkschmidt^2*, Ralf Dürrwald^3*, Sebastian Wolf, MD^2*, David Zurmeyer^2*, Björn Steffen, MD^2*, Evelyn Ullrich, MD⁴, Hubert Serve, MD², Thomas Oellerich, Prof. MD^2* and Ivana von Metzler, MD^5*

¹Department of Hematology and Oncology, Unversity Hospital Frankfurt, Frankfurt, Frankfurt Am Main, Germany
²Department of Hematology and Oncology, Unversity Hospital Frankfurt, Frankfurt, Frankfurt am Main, Germany
³Robert Koch-Institut, Berlin, Germany
⁴Experimental Immunology, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany, Frankfurt Am Main, DEU
⁵Department of Internal Medicine II, University Hospital Frankfurt a.M., Frankfurt a.M., Germany, Frankfurt am Main, Germany

Phillip Pham, MD^1*, Parvathi Sudha^2*, Lin Wang, PhD^3*, Wen Niu^4*, Cameron Morgan^4*, Cameron Ligocki^4*, Ramzi Al-Azzawi^4*, Reynold Ly^4*, Francesco Vetrini^4*, Magdalena Czader, MD, PhD^3*, Marwan Tayeh^4*, Mohammad Abu Zaid, MBBS², Kelvin P. Lee, MD², Attaya Suvannasankha^1*, Rafat Abonour, MD² and Brian A. Walker, PhD¹

¹Simon Comprehensive Cancer Center, Division of Hematology Oncology, Indiana University School of Medicine, Indianapolis, IN
²Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN
³Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN
⁴Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN

Florence Lachenal, MD^1*, Pierre Lebreton, MD^2*, Sylvie Bouillie, PhD^3*, Gian Matteo Pica, MD^4*, Hassina Aftisse, MD^5*, Laurent Pascal, MD⁶, Lydia Montes, MD^7*, Margaret Macro, MD^8*, Marguerite Vignon, MD^9*, Stephanie Harel, MD^10*, Mariana Fernandez^11*, Chanaz Louni^12*, Antoine Huart, MD^13* and Aurore Perrot, MD, PhD¹⁴

¹GHND Groupement Hospitalier Nord Dauphiné, Bourgoin Jallieu, France
²Groupe Hospitalier du Havre, Le Havre, France
³Janssen, Issy-les-Moulineaux, France
⁴Hematology department, CH Chambery, Chambery, France
⁵Centre Hospitalier de Saint Quentin, Saint Quentin, France
⁶Hôpital Saint Vincent de Paul, Lille, France
⁷Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
⁸Hopital Cote De Nacre, Caen, France
⁹Hématologie Clinique, Hôpital Cochin, AP-HP, Paris, France
¹⁰Saint Louis Hospital, Paris, France
¹¹Janssen Cilag Spain, Madrid, Spain
¹²IFM, Paris, France
¹³Department of Nephrology and Transplantation, CHU de Toulouse Rangueil, Toulouse, France
¹⁴CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France

Bin Chu, MD^*, Yutong Wang, MD^*, Lei Shi^*, Kai Sun, MD^* and Li Bao^*

Department of Hematology, Beijing JiShuiTan Hospital, Capital Medical University, Beijing, China

Beth Gordon, MD^1*, Lindsay Fogel, BS^2*, Gaurav Varma, MD, MSPH^1*, Mateo Mejia Saldarriaga, MD³, Jaeil Ahn, PhD^4*, Adolfo Aleman, MD^5*, Jessica Caro, MD⁶, Xiaoyi Chen, MD, PhD^1*, Jorge Monge, MD³, Harsh Parmar, MBBS⁵, David Kaminetzky, MD^1*, Tibor Moskovits, MD¹, David S. Siegel, MD, PhD⁷, Gareth J. Morgan, M.D., Ph.D.^1*, Ruben Niesvizky, MD³, Noa Biran, MD⁵ and Faith E. Davies, MD⁸

¹Myeloma Research Program, Perlmutter Cancer Center, NYU Langone Health, New York, NY
²Multiple Myeloma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
³Myeloma Program, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY
⁴Georgetown University, Washington, DC
⁵Multiple Myeloma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
⁶Zuckerberg Cancer Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY
⁷Multiple Myeloma Division, Hackensack Univ. Med. Ctr., Hackensack, NJ
⁸Perlmutter Cancer Center, Multiple Myeloma Research Program, NYU Grossman School of Medicine, NYU Langone Health, New York, NY

Dajung Kim, MD, PhD^1*, Seri Jeong^2*, Kevin Song, MD, FRCPC³, Jae-Cheol Jo, MD⁴, JiHyun Lee^5*, Jee-Yeong Jeong, PhD⁶ and Ho Sup Lee, MD^7*

¹Department of Internal Medicine, Kosin University Gospel Hospital, Busan,, Korea, Republic of (South)
²Department of Laboratory Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea, Republic of (South)
³BC Cancer Agency, Vancouver General Hospital, Vancouver, BC, Canada
⁴Ulsan University Hospital, Ulsan, KOR
⁵Department of Internal Medicine,, Dong-A Medical Center, Dong-A University College of Medicine, Busan, Korea, Busan, Korea, Republic of (South)
⁶Kosin University College of Medicine, Busan, KOR
⁷Kosin University Gospel Hospital, Busan, Korea, Republic of (South)

Elina Alaterre, PhD^1*, Nicolas Robert^2*, Guilhem Requirand^2*, Amélie Machura^1*, Hugues De Boussac, PhD^1*, Laure Vincent, MD^3*, Charles Herbaux, MD, PhD^4*, Angélique Bruyer^1* and Jerome Moreaux, PhD^2,5,6

¹Diag2tec, Montpellier, France
²Department of Biological Hematology, Montpellier University Hospital Center, Laboratory for Monitoring Innovative Therapies, Montpellier, France
³Department of Clinical Hematology, Montpellier University Hospital Center, Montpellier, France
⁴Clinical Hematology Department, Montpellier University Hospital, MONTPELLIER, France
⁵Université Montpellier, Montpellier, France
⁶Institute of Human Genetics, CNRS UM UMR 9002, University of Montpellier, MONTPELLIER, France

Carlyn Tan, MD¹, Kylee H Maclachlan, MBChB, PhD¹, David Nemirovsky, MS^2*, Andriy Derkach, PhD^2*, Malin Hultcrantz, MD, PhD¹, Hani Hassoun, MD¹, Sham Mailankody, MBBS¹, Urvi A Shah, MD¹, Sridevi Rajeeve, MD¹, Dhwani Patel, MD^1*, Tala Shekarkhand, MS^1*, Colin Rueda^1*, Oscar Boutros Lahoud³, Gunjan L. Shah³, Michael Scordo³, David Chung, MD, PhD³, Heather Landau, MD³, Sergio A. Giralt, MD, FACP³, Alexander Lesokhin, MD¹, Saad Z Usmani, MD¹ and Neha Korde, MD¹

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Amalia Domingo-González^1*, Rafael Alonso Fernández, MD^2*, Ana Jiménez^3*, Teresa De Soto Alvarez^4*, Ana Lerma^5*, Virginia Pradillo Fernandez^6*, Gonzalo Benzo Callejo^7*, Jose Sanchez-Pina^2*, Elena Landete^8*, Alberto Velasco^9*, Marina Menéndez Cuevas^9*, Mónica María López Riñón^10*, Andrés Ramírez López^11*, Alberto Lopez Garcia, MD¹, María-Jesús Blanchard^3* and Elham Askari, MD^1*

¹Fundacion Jimenez Diaz University Hospital, Madrid, Spain
²Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
³Hematology, Hospital Universitario Ramon y Cajal, Madrid, Spain
⁴Hospital Universitario La Paz, Madrid, ESP
⁵Hospital General Nuestra Señora del Prado, Toledo, Spain
⁶Hospital Universitario Quirón Pozuelo, Madrid, ESP
⁷Hospital Universitario La Princesa, Galdakao, ESP
⁸Hospital Universitario Infanta Leonor, Madrid, Spain
⁹Hospital Rey Juan Carlos, Madrid, Spain
¹⁰Hospital General de Tomelloso, Ciudad Real, Spain
¹¹Hospital General La Mancha Centro, Ciudad Real, Spain